Vitamin D Products

(off-site)

Donate via PayPal

Your tax-deductable gift will help us to be more effective in our mission to end the worldwide epidemic of vitamin D deficiency.

Vitamin D On The Web

See our Vitamin D News page for all the latest vitamin D headlines from around the globe.

Our Best Vitamin D Articles page for links to informative, less-mainstream articles on vitamin D and UV exposure.

Vitamin D Research

back to research menu

Treatment

Undertreatment of osteoporosis following hip fracture in the elderly. Arch Gerontol Geriatr. 2009 Jul–Aug;49(1):153–7.
Changes of the quality-of-life under the treatment of severe senile osteoporosis with teriparatide. Arch Gerontol Geriatr. 2009 Jul–Aug;49(1):35–8.
Vitamin D insufficiency does not affect response of bone mineral density to alendronate. Osteoporos Int. 2009 Jul;20(7):1259–66.
Effects of a multi-component exercise program and calcium-vitamin-D3-fortified milk on bone mineral density in older men: a randomised controlled trial. Osteoporos Int. 2009 Jul;20(7):1241–51.
Response of different PTH assays to therapy with sevelamer or CaCO3 and active vitamin D sterols. Pediatr Nephrol. 2009 Jul;24(7):1355–61.
Vitamin D treatment in multiple sclerosis. J Neurol Sci. 2009 Jun 22.
1,25-Dihydroxyvitamin D3 induces Ca2+-mediated apoptosis in adipocytes via activation of calpain and caspase-12. Biochem Biophys Res Commun. 2009 Jun 19;384(1):18–21.
Chronic inflammation in the pathogenesis of benign prostatic hyperplasia. Int J Androl. 2009 Jun 8.
Clinical Responses to a Mega-dose of Vitamin D3 in Infants and Toddlers With Vitamin D Deficiency Rickets. J Trop Pediatr. 2009 Jun 8.
Influence of vitamin D3 analogues in combination with budesonid R on proliferation of nasal polyp fibroblasts. Acta Biochim Pol. 2009 Jun 5.
Vitamin D for Treatment and Prevention of Infectious Diseases: A Systematic Review of Randomized Controlled Trials. Endocr Pract. 2009 Jun 2:1–29.
Activation of rapid signaling pathways does not contribute to 1alpha,25-dihydroxyvitamin D(3)-induced growth inhibition of mouse prostate epithelial progenitor cells. J Cell Biochem. 2009 Jun 2.
Comparison of oral falecalcitriol and intravenous calcitriol in hemodialysis patients with secondary hyperparathyroidism: a randomized, crossover trial. Clin Nephrol. 2009 Jun;71(6):660–8.
Paricalcitol and outcome: A manual on how a vitamin D receptor activator (VDRA) can help us to get down the "U". Clin Nephrol. 2009 Jun;71(6):593–601.
Resistance to vitamin D treatment as an indication of celiac disease in a patient with primary hypoparathyroidism. Clinics. 2009 Jun;64(3):259–61.
Vitamin D as Adjunctive Therapy in Refractory Pulmonary Tuberculosis: A Case Report. South Med J. 2009 May 7.
Vitamin d and tuberculosis: new light on a potent biologic therapy? Am J Respir Crit Care Med. 2009 May 1;179(9):740–2.
Vitamin D as Supplementary Treatment for Tuberculosis — A Double-blind Randomized Placebo-controlled Trial. Am J Respir Crit Care Med. 2009 May 1;179(9):843–50.
Severe proximal myopathy with remarkable recovery after vitamin D treatment. Can J Neurol Sci. 2009 May;36(3):336–9.
Vitamin d. Int J Biochem Cell Biol. 2009 May;41(5):982–5.
Long-term effects of giving nursing home residents bread fortified with 125 microg (5000 IU) vitamin D(3) per daily serving. Am J Clin Nutr. 2009 Apr;89(4):1132–7.
Alendronate/vitamin D3 70 mg/2800 IU with and without additional 2800 IU vitamin D3 for osteoporosis: results from the 24-week extension of a 15-week randomized, controlled trial. Bone. 2009 Apr;44(4):639–47.
Responses of parathyroid hormone to vitamin D supplementation: a systematic review of clinical trials. Arch Gerontol Geriatr. 2009 Mar–Apr;48(2):160–6.
Myalgias or non-specific muscle pain in Arab or Indo-Pakistani patients may indicate vitamin D deficiency. Clin Rheumatol. 2009 Mar 10.
The combination of vitamin D(3) and dehydroascorbic acid administration attenuates brain damage in focal ischemia. Neurol Sci. 2009 Mar 6.
The efficacy and safety of calcitriol and/or Caltrate D in elderly Chinese women with low bone mass. Acta Pharmacol Sin. 2009 Mar;30(3):372–8.
The effect of combined calcium and vitamin D3 supplementation on serum intact parathyroid hormone in moderate CKD. Am J Kidney Dis. 2009 Mar;53(3):408–16.
Alteration of DBP levels in CSF of patients with MS by proteomics analysis. Cell Mol Neurobiol. 2009 Mar;29(2):203–10.
Increasing use of more potent treatments for psoriasis. J Am Acad Dermatol. 2009 Mar;60(3):478–81.
Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancer. Int J Colorectal Dis. 2009 Feb;24(2):219–24.
Vitamin D as Supplementary Treatment for Tuberculosis — A Double-blind Randomized Placebo-controlled Trial. Am J Respir Crit Care Med. 2009 Jan 29.
The Effect of Combined Calcium and Vitamin D(3) Supplementation on Serum Intact Parathyroid Hormone in Moderate CKD. Am J Kidney Dis. 2009 Jan 28.
Influence of a single oral dose of vitamin D(2) on serum 25-hydroxyvitamin D concentrations in tuberculosis patients. Int J Tuberc Lung Dis. 2009 Jan;13(1):119–25.
A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med. 2009 Jan;26(1):19–27.
Low serum 25 (OH) vitamin D levels (<32 ng/mL) are associated with reversible myositis-myalgia in statin-treated patients. Transl Res. 2009 Jan;153(1):11–6.
Prevalence of vitamin D deficiency rickets in the eastern part of Turkey. Eur J Pediatr. 2009 Jan;168(1):95–100.
Vitamin D and the vasculature: can we teach an old drug new tricks? Expert Opin Ther Targets. 2009 Jan;13(1):29–38.
Improving detection and treatment of osteoporosis: redesigning care using the electronic medical record and shared medical appointments. Osteoporos Int. 2009 Jan;20(1):37–42.
Predictors of Adherence in the Women's Health Initiative Calcium and Vitamin D Trial. Behav Med. 2009 Winter;34(4):145–55.
Effect of a Combined Therapeutic Approach of Intensive Lipid Management, Omega-3 Fatty Acid Supplementation, and Increased Serum 25 (OH) Vitamin D on Coronary Calcium Scores in Asymptomatic Adults. Am J Ther. 2008 Dec 15.
Vitamin d deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol. 2008 Dec 9;52(24):1949–56.
Influence of Neonatal Vitamin A or Vitamin D Treatment on the Concentration of Biogenic Amines and their Metabolites in the Adult Rat Brain. Horm Metab Res. 2008 Dec 3.
Suppression of renin-angiotensin gene expression in the kidney by paricalcitol. Kidney Int. 2008 Dec;74(11):1394–402.
Preoperative vitamin D replacement therapy in primary hyperparathyroidism: safe and beneficial? Surgery. 2008 Dec;144(6):852–8; discussion 858–9.
Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial. J Intern Med. 2008 Dec;264(6):599–609.
Effect of Roux-en Y Gastric Bypass on Bone Metabolism in Patients with Morbid Obesity: Mansoura Experiences. Obes Surg. 2008 Dec;18(12):1526–31.
Vitamin D Receptor Genotype in Hypophosphatemic Rickets as a Predictor of Growth and Response to Treatment. J Clin Endocrinol Metab. 2008 Dec;93(12):4672–82.
Closing the Gap: Bone Health Education in Orthopaedic Practice. Orthop Nurs. 2008 Nov–Dec;27(6):340–6; quiz 347–8.
Risk factors of musculoskeletal ambulation disability symptom complex (MADS). - Frequent falls and sarcopenia according to aging -. Clin Calcium. 2008 Nov;18(11):1581–7.
Phytochemicals and regulation of the adipocyte life cycle. J Nutr Biochem. 2008 Nov;19(11):717–26. Review.
Vitamin D and musculoskeletal health. Nat Clin Pract Rheumatol. 2008 Nov;4(11):580–8.
Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Mult Scler. 2008 Nov;14(9):1220–1224.
Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers. Nephrol Dial Transplant. 2008 Nov;23(11):3670–6.
Inadequate responders to osteoporosis treatment: proposal for an operational definition. Osteoporos Int. 2008 Nov;19(11):1511–6.
Prevention of anastrozole-induced bone loss with monthly oral ibandronate during adjuvant aromatase inhibitor therapy for breast cancer. Clin Cancer Res. 2008 Oct 1;14(19):6336–42.
Vanadium and 1, 25 (OH)(2) vitamin D(3) combination in inhibitions of 1,2, dimethylhydrazine-induced rat colon carcinogenesis. Biochim Biophys Acta. 2008 Oct;1780(10):1106–14.
Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model. Cancer Chemother Pharmacol. 2008 Oct;62(5):787–97.
Prostate-derived Ets transcription factor as a favorable prognostic marker in ovarian cancer patients. Int J Cancer. 2008 Sep 15;123(6):1376–84.
Pediatric vitamin D and calcium nutrition in developing countries. Rev Endocr Metab Disord. 2008 Sep;9(3):181–92. Review.
Pattern of 25-hydroxy vitamin D response at short (2 month) and long (1 year) interval after 8 weeks of oral supplementation with cholecalciferol in Asian Indians with chronic hypovitaminosis D. Br J Nutr. 2008 Sep;100(3):526–9.
Implementing an intervention to improve bone mineral density in survivors of childhood acute lymphoblastic leukemia: BONEII, a prospective placebo-controlled double-blind randomized interventional longitudinal study design. Contemp Clin Trials. 2008 Sep;29(5):711–9.
Dietary supplement use among elderly, long-term cancer survivors. J Cancer Surviv. 2008 Sep;2(3):138–48.
Comparison of Daily, Weekly, and Monthly Vitamin D3 in Ethanol Dosing Protocols for Two Months in Elderly Hip Fracture Patients. J Clin Endocrinol Metab. 2008 Sep;93(9):3430–5.
Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. J Clin Endocrinol Metab. 2008 Aug;93(8):3015–20.
25-Hydroxyvitamin D Levels and the Risk of Mortality in the General Population. Arch Intern Med. Vol. 168 No. 15, Aug 11/25, 2008.
Osteoarthritis. Best Pract Res Clin Rheumatol. 2008 Aug;22(4):657–75.
Vitamin D receptor activators can protect against vascular calcification. J Am Soc Nephrol. 2008 Aug;19(8):1509–19.
Vitamin D derivatives acutely reduce endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol. 2008 Jul;295(1):H289–96.
Salmon calcitonin in prevention of osteoporosis in maintenance dialysis patients. Chin Med J (Engl). 2008 Jul 20;121(14):1280–4.
L-arginine and vitamin D: novel adjunctive immunotherapies in tuberculosis. Trends Microbiol. 2008 Jul;16(7):336–44. Review.
The remodeling transient and the calcium economy. Osteoporos Int. 2008 Jul;19(7):1001–9.
Vitamin D and anti-aging medicine. Clin Calcium. 2008 Jul;18(7):980–5. Review in Japanese.
Dietary manipulation in musculoskeletal conditions. Best Pract Res Clin Rheumatol. 2008 Jun;22(3):535–61. Review.
3-year follow-up of 215 fracture patients from a prospective and consecutive osteoporosis screening program. Fracture patients care! Acta Orthop. 2008 Jun;79(3):404–9.
Prevention, diagnosis, and treatment of glucocorticoid induced osteoporosis by rheumatologists in a Latin-American city. J Clin Rheumatol. 2008 Jun;14(3):153–5.
Secondary osteoporosis in long-term bedridden patients with cerebral palsy. Pediatr Int. 2008 Jun;50(3):269–75.
Mineral metabolism and bone abnormalities in children with chronic renal failure. Rev Endocr Metab Disord. 2008 Jun;9(2):131–7. Review.
Influence of adjuvant pain medication on quality of life in the treatment of postmenopausal osteoporosis. Orthopade. 2008 May;37(5):435–9. In German.
Seemingly paradoxical seasonal influences on vitamin D status in nursing-home elderly people from a Mediterranean area. Nutrition. 2008 May;24(5):414—20.
Insulin resistance, renal injury, renal 1-alpha hydroxylase, and bone homeostasis in aged obese rats. Arch Med Res. 2008 May;39(4):380–7.
Effects of antiosteoporotic agents on glucose and lipid metabolism and cardiovascular system. Clin Calcium. 2008 May;18(5):677–84. Review in Japanese.
New insights into the role of vitamin D and calcium in osteoporosis management: an expert roundtable discussion. Curr Med Res Opin. 2008 May;24(5):1363–70. Review.
OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. J Bone Miner Res. 2008 May;23(5):715–20.
Generalized metabolic bone disease in Neurofibromatosis type I. Mol Genet Metab. 2008 May;94(1):105–11.
Calcium and vitamin D intake influence bone mass, but not short-term fracture risk, in Caucasian postmenopausal women from the National Osteoporosis Risk Assessment (NORA) study. Osteoporos Int. 2008 May;19(5):673–9.
Sickle cell bone disease: response to vitamin D and calcium. Am J Hematol. 2008 Apr;83(4):271–4.
The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells. Clin Exp Rheumatol. 2008 Mar–Apr;26(2):295–304.
Diffuse musculoskeletal pain is not associated with low vitamin D levels or improved by treatment with vitamin D. J Clin Rheumatol. 2008 Feb;14(1):12–6.
Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study. Endocr Pract. 2008 Jan–Feb;14(1):10–7.
Vitamin D supplementation has minor effects on parathyroid hormone and bone turnover markers in vitamin D-deficient bedridden older patients. Age Ageing. 2008 Jan;37(1):25–31.
The effect of a single dose versus a daily dose of cholecalciferol on the serum 25-hydroxycholecalciferol and parathyroid hormone levels in the elderly with secondary hyperparathyroidism living in a low-income housing unit. J Bone Miner Metab. 2008;26(6):603–8.
Vitamin D deficiency in psychiatric in-patients and treatment with daily supplements of calcium and ergocalciferol. Psychiatric Bulletin (2008) 32: 390–393.
Therapeutic potential of vitamin D for multiple sclerosis. Curr Med Chem. 2008;15(5):499–505. Review.
The effect of a combined oral calcium and vitamin D supplement for treating mild to moderate vitamin D deficiency in postmenopausal women. Clin Interv Aging. 2008;3(1):183–6.
Vitamin D deficiency and primary hyperparathyroidism. J Bone Miner Res. 2007 Dec;22 Suppl 2:V100–4. Review.
Vitamin D insufficiency/deficiency in gastrointestinal disorders. J Bone Miner Res. 2007 Dec;22 Suppl 2:V50–4. Review.
Dose response to vitamin D supplementation among postmenopausal African American women. Am J Clin Nutr. 2007 Dec;86(6):1657–62.
Vitamin D receptor agonists in the treatment of autoimmune diseases: selective targeting of myeloid but not plasmacytoid dendritic cells. J Bone Miner Res. 2007 Dec;22 Suppl 2:V69–73. Review.
The antitumor effect of lowered doses of cytostatics combined with new analogs of vitamin D in mice. Anticancer Res. 2007 Sep–Oct;27(5A):3387–98.
Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD. Am J Kidney Dis. 2007 Jul;50(1):59–68.
Bone mineral density and bone markers in patients with a recent low-energy fracture: effect of 1 y of treatment with calcium and vitamin D. Am J Clin Nutr. 2007 Jul;86(1):251–9.
Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr. 2007 Jun;85(6):1586–91.
Vitamin d and rehabilitation: improving functional outcomes. Nutr Clin Pract. 2007 Jun;22(3):297–304. Review.
Vitamin D status of patients admitted to a hospital rehabilitation unit: relationship to function and progress. Am J Phys Med Rehabil. 2007 Jun;86(6):435–45.
Successful treatment of refractory warts with topical vitamin D(3) derivative (maxacalcitol, 1alpha, 25-dihydroxy-22-oxacalcitriol) in 17 patients. J Dermatol. 2007 Apr;34 (4):264–6.
Treatment of pigmented lesions of neurofibromatosis 1 with intense pulsed-radio frequency in combination with topical application of vitamin D(3) ointment. J Dermatol. 2007 Apr;34 (4):227–30.
Circulating Vitamin D3 and 25-hydroxyvitamin D in Humans: An Important Tool to Define Adequate Nutritional Vitamin D Status. J Steroid Biochem Mol Biol. 2007 March; 103(3–5): 631–634.
Natural approaches to epilepsy. Altern Med Rev. 2007 Mar;12(1):9–24. Review.
A meta-analysis of second cancers after a diagnosis of nonmelanoma skin cancer: Additional evidence that solar ultraviolet-B irradiance reduces the risk of internal cancers. J Steroid Biochem Mol Biol. 2007 Mar;103(3–5):668–74.
Medical management of patients over 50 years admitted to orthopedic surgery for low-energy fracture. Joint Bone Spine. 2007 Mar;74(2):160–5.
Inhibition of prostate growth and inflammation by the vitamin D receptor agonist BXL-628 (elocalcitol). J Steroid Biochem Mol Biol. 2007 Mar;103(3–5):689–93.
Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial). Rheumatol Int. 2007 Mar;27(5):425–34.
Nutritional vitamin D deficiency presenting as hemichorea. J Child Neurol. 2007 Jan;22(1):74–6.
Osteomalacia and secondary hyperparathyroidism after kidney transplantation: Relationship to vitamin D deficiency. Am J Med Sci. 2007 Jan;333(1):58–62.
Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease. Am J Nephrol. 2007;27(1):36–43.
Optimal vitamin D status for the prevention and treatment of osteoporosis. Drugs Aging. 2007;24(12):1017–29. Review.
The effect of combined treatment on head and neck human cancer cell lines with novel analogs of calcitriol and cytostatics. Oncol Res. 2007;16(11):517–25.
Cancer survival is dependent on season of diagnosis and sunlight exposure. Int J Cancer. 2006 Oct 1;119(7):1530–6.
Renal tubular acidosis type 2 with Fanconi's syndrome, osteomalacia, osteoporosis, and secondary hyperaldosteronism in an adult consequent to vitamin D and calcium deficiency: effect of vitamin D and calcium citrate therapy. Endocr Pract. 2006 Sep–Oct;12(5):559–67.
A system for improving vitamin D nutrition in residential care. Med J Aust. 2006 Aug 21;185(4):195–8.
Effect of vitamin D supplementation on vitamin D status and bone turnover markers in young adults. Eur J Clin Nutr. 2006 Jun;60(6):727–33.
Vitamin D2 dose required to rapidly increase 25OHD levels in osteoporotic women. Eur J Clin Nutr. 2006 May;60(5):681–7.
Effect of vitamin D and calcium supplementation on bone turnover in institutionalized adults with Down's Syndrome. Eur J Clin Nutr. 2006 May;60(5):605–9.
Public health strategies to overcome barriers to optimal vitamin d status in populations with special needs. J Nutr. 2006 Apr;136(4):1135–9.
Human Mammary Epithelial Cells Express CYP27B1 and Are Growth Inhibited by 25-Hydroxyvitamin D-3, the Major Circulating Form of Vitamin D-3. J Nutr. 2006 Apr;136(4):887–92.
Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006 Mar 24;311(5768):1770–3.
Vitamin d levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine. Epilepsia. 2006 Mar;47(3):510–5.
Superiority of alfacalcidol compared to vitamin D plus calcium in lumbar bone mineral density in postmenopausal osteoporosis. Rheumatol Int. 2006 Mar;26(5):445–53.
Oral treatment with a vitamin D3 analogue (BXL628) has anti-inflammatory effects in rodent model of interstitial cystitis. BJU International Volume 97 Page 617—March 2006.
Nutraceuticals: do they work and when should we use them? Best Pract Res Clin Rheumatol. 2006 Feb;20(1):99–115. Review.
Pharmacological treatment to augment hole board habituation in prenatal Vitamin D-deficient rats. Behav Brain Res. 2006 Jan 6;166(1):177–83.
Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation. Kidney Int. 2006 Jan;69(1):33–43. Review.
1,25-Dihydroxyvitamin D inhibits lipopolysaccharide-induced immune activation in human endothelial cells. Clin Exp Immunol. 2006 Jan;143(1):58–64.
Effects of vitamin D analogs on the expression of plasminogen activator inhibitor-1 in human vascular cells. Thromb Res. 2006;118(6):709–14.
Colon cancer and solar ultraviolet B radiation and prevention and treatment of colon cancer in mice with vitamin D and its Gemini analogs. J Steroid Biochem Mol Biol. 2005 Oct;97(1–2):111–20.
Annual intramuscular injection of a megadose of cholecalciferol for treatment of vitamin D deficiency: efficacy and safety data. Med J Aust. 2005 Jul 4;183(1):10–2.
Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J. 2005 Jul;19(9):1067–77.
Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study. Clin Rheumatol. 2005 Jun;24(3):232–8.
Vitamin D and calcium supplementation prevents severe falls in elderly community-dwelling women: a pragmatic population-based 3-year intervention study. Aging Clin Exp Res. 2005 Apr;17(2):125–32.
Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ 2005;330:1003 (30 April).
Calcium and 1 alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease. Eur J Immunol. 2005 Jan;35(1):217–24.
Chemoprevention of prostate cancer by cholecalciferol (vitamin D3): 25-hydroxylase (CYP27A1) in human prostate epithelial cells. Clin Exp Metastasis. 2005;22(3):265–73.
A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis. JNNP 2005;76:1294–1296.
Inhibition of proliferation and induction of apoptosis by 25-hydroxyvitamin D3-3beta-(2)-Bromoacetate, a nontoxic and vitamin D receptor-alkylating analog of 25-hydroxyvitamin D3 in prostate cancer cells. Clin Cancer Res. 2004 Dec 1;10(23):8018–27.
Failure to normalize parathyroid hormone during treatment of vitamin D deficiency in Asian patients. Clin Endocrinol (Oxf). 2004 Nov;61(5):603–6.
Vitamin D supplementation improves neuromuscular function in older people who fall. Age Ageing. 2004 Nov;33(6):589–95.
Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004 Sep 1;173(5):2909–12.
Toxicity and antineoplastic effect of (24R)-1,24-dihydroxyvitamin D3 (PRI-2191). Steroids. 2004 Sep;69(10):629–35.
Vitamin D2 Is Much Less Effective than Vitamin D3 in Humans Journal of Clinical Endocrinology & Metabolism 2004 Aug Vol. 89, No. 11 5387–5391
Dendritic cells as key targets for immunomodulation by Vitamin D receptor ligands. J Steroid Biochem Mol Biol. 2004 May;89–90(1–5):437–41. Review.
Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway). Cancer Causes Control. 2004 Mar;15(2):149–58.
Prediction of bone mass density variation by bone remodeling markers in postmenopausal women with vitamin D insufficiency treated with calcium and vitamin D supplementation. J Clin Endocrinol Metab. 2003 Nov;88(11):5175–9.
Rescue of the pseudo-vitamin D deficiency rickets phenotype of CYP27B1-deficient mice by treatment with 1,25-dihydroxyvitamin D3: biochemical, histomorphometric, and biomechanical analyses. J Bone Miner Res. 2003 Apr;18(4):637–43.
Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes. Ann N Y Acad Sci. 2003 Apr;987:258–61. Review.
Calcium and vitamin D. Endocrinol Metab Clin North Am. 2003 Mar;32(1):181–94, vii–viii. Review.
Vitamin D analogs and breast cancer. Recent Results Cancer Res. 2003;164:333–48. Review.
Evaluation of vitamin D analogs as therapeutic agents for prostate cancer. Recent Results Cancer Res. 2003;164:273–88.
Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003;326:469 (1 March)
2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ. 2002 Nov 12;167(10 Suppl):S1–34. Review.
Plasma vitamin D and 25OHD responses of young and old men to supplementation with vitamin D3. J Am Coll Nutr. 2002 Aug;21(4):357–62.
The effect of conventional vitamin D(2) supplementation on serum 25(OH)D concentration is weak among peripubertal Finnish girls: a 3-y prospective study. Eur J Clin Nutr. 2002 May;56(5):431–7.
Role of Ca(2+) and vitamin D in the prevention and treatment of osteoporosis. Pharmacol Ther. 2002 Jan;93(1):37–49. Review.
Vitamin D analogs: new therapeutic agents for secondary hyperparathyroidism. Treat Endocrinol. 2002;1(5):313–27. Review.
Vitamin D analogues for secondary hyperparathyroidism. Nephrol Dial Transplant. 2002;17 Suppl 10:10–9. Review.
Vitamin D analogs for the treatment of secondary hyperparathyroidism. Blood Purif. 2002;20(1):109–12. Review.
Treatment of vitamin D deficiency due to Crohn's disease with tanning bed ultraviolet B radiation. Gastroenterology. 2001 Dec;121(6):1485–8.
Vitamin D analogues for the management of secondary hyperparathyroidism. Am J Kidney Dis. 2001 Nov;38(5 Suppl 5):S34–40. Review.
Wintertime vitamin D deficiency in male adolescents: effect on parathyroid function and response to vitamin D3 supplements. Osteoporos Int. 2001;12(10):875–9.
Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev. 2001;(1):CD000227. Review.
Vitamin D deficiency among immigrants. Ugeskr Laeger. 2000 Nov 13;162(46):6196–9. Review in Danish.
Osteomalacia in immigrants: therapeutic management of two cases. Med Klin (Munich). 2000 Aug 15;95(8):451–6. In German.
24,25-dihydroxyvitamin D3 in combination with 1,25-dihydroxyvitamin D3 ameliorates renal osteodystrophy in rats with chronic renal failure. Clin Nephrol. 2000 May;53(5):362–71.
1,25-dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis. J Neuroimmunol. 2000 Mar 1;103(2):171–9.
1,25-Dihydroxyvitamin D3—a hormone with immunomodulatory properties. Z Rheumatol. 2000;59 Suppl 1:24–7. Review.
Relationship between muscle strength and vitamin D metabolites: are there therapeutic possibilities in the elderly? Z Rheumatol. 2000;59 Suppl 1:39–41.
Plasma 25-hydroxyvitamin D responses of younger and older men to three weeks of supplementation with 1800 IU/day of vitamin D. J Am Coll Nutr. 1999 Oct;18(5):470–4.
Treatment of glucocorticoid-induced osteoporosis with alfacalcidol/calcium versus vitamin D/calcium. Calcif Tissue Int. 1999 Oct;65(4):337–40.
Vitamin D therapy of osteoporosis: plain vitamin D therapy versus active vitamin D analog (D-hormone) therapy. Calcif Tissue Int. 1999 Oct;65(4):295–306. Review.
Resolution of vitamin D insufficiency in osteopenic patients results in rapid recovery of bone mineral density. J Clin Endocrinol Metab. 1999 Aug;84(8):2729–30.
Vitamin D analogs: perspectives for treatment. Miner Electrolyte Metab. 1999 Jul–Dec;25(4–6):337–41. Review.
Disease caused by lack of sunlight: rickets and osteomalacia. Ned Tijdschr Geneeskd. 1999 Mar 20;143(12):593–7. Review in Dutch.
1,25-dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta 1 and IL-4. J Immunol. 1998 Jun 1;160(11):5314–9.
1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr. 1998 Jan;128(1):68–72.
Treatment of vitamin D deficient osteomalacia may unmask autonomous hyperparathyroidism. Postgrad Med J. 1997 Dec;73(866):813–5.
Subclinical vitamin D deficiency in neonates: definition and response to vitamin D supplements. Am J Clin Nutr. 1997 Mar;65(3):771–8.
Vitamin D prophylaxis in children with a single dose of 150,000 IU of vitamin D. Eur J Clin Nutr. 1996 Dec;50(12):807–10.
Therapy of osteoporosis: calcium, vitamin D, and exercise. Am J Med Sci. 1996 Dec;312(6):278–86. Review.
Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1996 Dec 15;125(12):961–8.
Clinical practice guidelines for the diagnosis and management of osteoporosis. Scientific Advisory Board, Osteoporosis Society of Canada. CMAJ. 1996 Oct 15;155(8):1113–33.
Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 8. Vitamin D metabolites and analogs in the treatment of osteoporosis. CMAJ. 1996 Oct 1;155(7):955–61. Review.
Vitamin D3 analogs and salmon calcitonin partially reverse the development of renal osteodystrophy in rats. Calcif Tissue Int. 1995 Nov;57(5):385–91.
Metabolic bone disease in gastrointestinal, hepatobiliary, and pancreatic disorders and total parenteral nutrition. Curr Opin Rheumatol. 1995 May;7(3):249–54. Review.
Possible role of 1,25-dihydroxyvitamin D3-induced metallothionein in photoprotection against UVB injury in mouse skin and cultured rat keratinocytes. J Dermatol Sci. 1995 May;9(3):203–8.
Characterization of a vitamin D3-resistant MCF-7 cell line. Endocrinology. 1996 Feb;137(2):400–9.
Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3. Endocrinology. 1995 Jan;136(1):20–6.
Single-dose cholecalciferol suppresses the winter increase in parathyroid hormone concentrations in healthy older men and women: a randomized trial. Am J Clin Nutr. 1994 May;59(5):1040–4.
24,25-dihydroxy vitamin D3 treatment inhibits parathyroid-stimulated adenylate cyclase in iliac crest biopsies from uremic patients. Bone. 1993 Mar-Apr;14(2):125–31.
Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3. Miner Electrolyte Metab. 1993;19(2):78–85.
Vitamin D supplementation in institutionalized elderly. Effects of vitamin D3 (100,000 IU) orally administered every 3 months on serum levels of 25-hydroxyvitamin D. Rev Rhum Mal Osteoartic. 1990 Nov;57(11):809–13.
Reduced deposition of aluminium in trabecular bone of uraemic rats treated with dihydroxylated vitamin D metabolites. Nephrol Dial Transplant. 1989;4(11):957–65.
Effects of 1 alpha,25- and 24R,25-dihydroxyvitamin D3 on aluminum-induced rickets in growing uremic rats. J Bone Miner Res. 1987 Dec;2(6):533–45.
Skin as the site of vitamin D synthesis and target tissue for 1,25-dihydroxyvitamin D3. Use of calcitriol (1,25-dihydroxyvitamin D3) for treatment of psoriasis. Arch Dermatol. 1987 Dec;123(12):1677–1683a. Review.
Main endocrine modulators of vitamin D hydroxylases in human pathophysiology. J Steroid Biochem. 1987;27(4–6):815–24. Review.
Studies on the hydroxylation of vitamin D in man. Ann Med Interne (Paris). 1986;137(3):206–8.
Deficiency rickets in an adolescent girl. Arch Fr Pediatr. 1985 Jun–Jul;42(6):443–5.
Vitamin D. II. Clinico-therapeutic implications. Med Clin (Barc). 1985 May 4;84(17):700–11. Review in Spanish.
Vitamin D metabolism and osteomalacia in cystic fibrosis. Gastroenterology. 1985 Mar;88(3):808–13.
Vitamin D deficiency: a risk factor for osteomalacia in the aged. J Am Geriatr Soc. 1983 Oct;31(10):598–601.
Hypoparathyroidism during pregnancy: treatment with calcitriol. J Clin Endocrinol Metab. 1981 Apr;52(4):810–3.
A case of hypoparathyroidism in a child with beta-thalassemia successfully treated with 1 alpha-hydroxy-vitamin D3. Helv Paediatr Acta. 1981;36(2):171–3.
Case report: hypoparathyroidism and iron storage disease. Treatment with 25-hydroxy-vitamin D3. Am J Med Sci. 1978 Nov–Dec;276(3):363–8.
1alpha-hydroxycholecalciferol in the treatment of hypoparathyroidism. Acta Med Scand. 1977 Jan;201(1–2):3–7.
Vitamin D: the discovery of its metabolites and their therapeutic applications. Pediatrics. 1976 May;57(5):729–41. Review.
Treatment of hypoparathyroidism with 1,25-dihydroxycholecalciferol. Clin Endocrinol (Oxf). 1976;5 Suppl:167S–173S.
The kidney as an endocrine organ involved in the function of vitamin D. Am J Med. 1975 Jan;58(1):39–47. Review.
"Anticonvulsant action" of vitamin D in epileptic patients? A controlled pilot study. Br Med J. 1974 May 4;2(5913):258–9.
Total urinary hydroxyproline in osteomalacia and the effect upon it of treatment with vitamin D. Clin Sci. 1968 Feb;34(1):43–56.

back to research menu

Unless otherwise expressly stated, all site content licensed under a Creative Commons License.